The balance between cell dierentiation and proliferation is regulated at the transcriptional level. In the cell cycle, the transition from G1 to S phase (G1/S transition) is of paramount importance in this regard. Indeed, it is only before this point that cells can be oriented toward the dierentiation pathway: beyond, cells progress into the cycle in an autonomous manner. The G1/S transition is orchestrated by the transcription factor E2F. E2F controls the expression of a group of checkpoint genes whose products are required either for the G1-to-S transition itself or for DNA replication (e.g. DNA polymerase a). E2F activity is repressed in growth-arrested cells and in early G1, and is activated at mid-to-late G1. E2F is controlled by the retinoblastoma tumor suppressor protein Rb. Rb represses E2F mainly by recruiting chromatin remodeling factors (histone deacetylases and SWI/SNF complexes), the DNA methyltransferase DNMT1, and a histone methyltransferase. This review will focus on the molecular mechanisms of E2F repression by Rb during the cell cycle and during cell-cycle exit by dierentiating cells. A model in which Rb irreversibly represses E2F-regulated genes in dierentiated cells by an epigenetic mechanism linked to heterochromatin, and involving histone H3 and promoter DNA methylation, is discussed. Oncogene (2001) 20, 3128 ± 3133.
Introduction
E2F controls the G1/S transition, a critical moment in the cell cycle, by regulating the transcription of families of genes whose products are either required for DNA synthesis or involved in the regulation of S phase entry (Johnson et al., 1993) . E2F is under the control of the retinoblastoma protein Rb (Flemington et al., 1993; Helin et al., 1993) (for review see Grana et al., 1998) and of CREB Binding Protein, CBP (Trouche et al., 1996; . Rb, whose inactivation is associated with the development of retinoblastoma and other types of human cancers (for reviews see Weinberg, 1992 Weinberg, , 1995 , is a member of the`pocket proteins' family that also includes p130 and p107 (for reviews see Grana et al., 1998; Mulligan and Jacks, 1998) . Rb exerts its anti-proliferative activity, at least in part, by inhibiting the E2F transcription factor. Rb is regulated by phosphorylation: in non-cycling cells, or in early G1, Rb is hypophosphorylated and inhibits E2F activity; during G1, Rb is progressively phosphorylated by cyclin-CDK complexes (for review see Harbour and Dean, 2000) and, as a consequence, loses its anity for E2F. The release of Rb triggers the activation of E2F target genes, which allows the cells to proceed through the G1/S transition.
Rb physically interacts with E2F's transactivation domain (Flemington et al., 1993; Helin et al., 1993; Ross et al., 1999) . It is thought that the masking of this domain participates in E2F inhibition. In addition, a second mechanism is based on active repression: Rb recruits`chromatin remodeling factors', including Histone Deacetylases (HDACs) (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) , members of the ATP-dependent chromatin remodeling complex SWI/SNF (Dunaief et al., 1994; Trouche et al., 1997) , DNA Methyltransferase 1 (DNMT1) , and a Histone H3 Methyltransferase (most likely Suv39H1) (Didier Trouche, personal communication).
Chromatin remodeling factors
In eukaryotes, genomic DNA is packaged by histones (H1, H2A, H2B, H3, and H4) and non-histone proteins into chromatin, the basic unit of which is the nucleosome. Linker histones, non-histone proteins, and potential interactions of core histone N-terminal tails with adjacent nucleosomes contribute to compaction/folding of nucleosomal DNA and formation of higher order structures. These structures restrict the access of proteins in general, and in particular that of proteins involved in transcription (reviewed in Felsenfeld, 1992; Kingston and Narlikar, 1999) .
Dynamic changes in chromatin structure facilitate or prevent the access of transcription factors to nucleosomal DNA. At least two mechanisms can be used to alter or remodel chromatin structure. One mechanism involves multi-subunit protein complexes that use ATP as a source of energy to remodel nucleosomes (e.g. SWI/SNF, NURF, RSC, CHRAC, and ACF) (reviewed in Kingston and Narlikar, 1999; Oncogene (2001) 20, 3128 ± 3133 Yaniv, 1999; Tyler and Kadonaga, 1999) . These complexes alter chromatin structure by changing the location and/or conformation of the nucleosomes (Hamiche et al., 1999) . A second mechanism involves covalent modi®cations either of DNA or of histone Nterminal tails that protrude from the core nucleosome. DNA can be methylated at position 5 of cytosine within CpG dinucleotides (reviewed in Bird and Wole, 1999; Ng and Bird, 1999; Singal and Ginder, 1999) , a modi®cation that is associated with transcriptional repression; this methylation in¯uences chromatin structure as well as gene activity (reviewed in Ng and Bird, 1999; Razin, 1998) . DNA is methylated by Methyltransferases (DNMTs). Sequences that include methylcytosines are speci®cally recognized by Methylcytosine Binding Proteins (MBDs) such as MeCP2 and MBDs 1/2/3. MBDs have been shown to be transcriptional repressors (for reviews see Singal and Ginder, 1999) . Histone tails can be modi®ed in several ways, including phosphorylation (Nowak and Corces, 2000; Wei et al., 1998) , methylation Strahl et al., 1999) , and acetylation (Roth and Allis, 1996) . The acetylation status of lysine residues in the core histone tails is under the control of nuclear Histone Acetyl-Transferases (HATs) and of Histone Deacetylases (HDACs). Several mammalian HATs have been identi®ed. These include the transcriptional coactivators CBP/p300, PCAF, GCN5L, SRC1, ACTR and TAFII250 (for reviews see Berger, 1999; Roth and Allis, 1996; Wade and Wole, 1997) . On the other hand, eight HDACs have been characterized to date (HDACs 1 to 8). A general correlation between histone acetylation and gene activity in vivo is now well established, although there are some exceptions. Furthermore, a number of transcriptional coactivators display a histone acetyltransferase activity; and several transcriptional corepressors have, or recruit, a histone deacetylase activity.
Several models have been proposed for the involvement of HATs and HDACs in transcription (reviewed in Kingston and Narlikar, 1999) . However, how core histone acetylation or deacetylation modulates transcription remains to be fully elucidated. HATs and HDACs are generally contained in multimolecular complexes. Some of these complexes, such as the Mi2/NURD complex, also include remodeling factors and methyl-CpG binding activities (Nan et al., 1998; Wade et al., 1999; Zhang et al., 1999) . Silencing of gene transcription by DNA methylation has been shown to involve the recruitment of the histone deacetylasecontaining complexes Sin3 and Mi2/NURD, which include the methyl-CpG binding proteins MeCP2 and MBD2/3, respectively (Nan et al., 1998; Wade et al., 1999; Zhang et al., 1999) . This interaction suggests a mechanistic explanation for the relationship between DNA methylation and chromatin structure. In this model, DNA methylation provides a signal for the recruitment, via the methylcytosine-binding proteins, of multimolecular repressive complexes that contain HDACs. Core histones tails are also modi®ed by phosphorylation on speci®c serine residues (Nowak and Corces, 2000; Wei et al., 1998) , and by methylation of distinct speci®c lysine residues Strahl et al., 1999) . These modi®cations seem to play a role in chromatin remodeling and might be important for the epigenetic regulation of gene expression. They seem to act in concert with ATP-dependent chromatin remodeling complexes to achieve chromatin remodeling and regulation of gene activity.
One of the questions that remains without a clear answer to date is the order of intervention of each of these partners: HATs or HDACs, remodeling complexes, DNA (and other) methylases (such as histone methyl-transferases). ATP-dependent chromatin remodeling complexes are involved in either activation or inhibition of transcription (Holstege et al., 1998) . A number of experimental observations suggest that, for transcriptional activation, the action of the ATPdependent complexes precedes the action of HATs (Cosma et al., 1999;  for review see Kingston and Narlikar, 1999) . The mechanism responsible for their recruitment to speci®c target genes is a matter of speculation. In some instances, chromatin remodeling complexes have been shown to be recruited through their interactions with DNA-bound transcriptional regulators (Workman and Kingston, 1998) . This requires, however, that the transcription factors have access to the DNA before the action of remodeling complexes, and thus that the initial structure have some level of accessibility. In this regard, sub-nuclear localization could provide a clue as to how this general level of accessibility is achieved.
Spatio-temporal chromatin organization and regulation of gene expression
The chromatin structure and its level of condensation are not homogeneous in cell nuclei. In the interphase nucleus, individual chromosomes occupy speci®c spaces referred to as chromosome territories (Schardin et al., 1985) . The active genes are preferentially localized either to the periphery of these chromosome territories or in the central nucleoplasm (Kurz et al., 1996; Wansink et al., 1996;  for review see Lamond and Earnshaw, 1998) . During interphase, there are two structural forms of chromatin: euchromatin, which is in a decondensed state and transcriptionally active, and heterochromatin (including centromeric and telomeric regions), which is condensed and generally transcriptionally inactive (reviewed in Gregory and Horz, 1998; Kadonaga, 1998; Wole and Pruss, 1996) . Heterochromatin contains relatively few genes, replicates in late S phase and is enriched in speci®c nuclear proteins. Localization in heterochromatin generally results in transcriptional silencing of a gene that would otherwise be active (Cockell et al., 1995; Francastel et al., 1999; Gottschling et al., 1990; Maillet et al., 1996) . This position eect' is regulated by speci®c proteins associated with heterochromatin. Heterochromatin contains large protein complexes that localize along the chromatin ®ber and seem to silence genes with Oncogene Rb/chromatin connection R Ferreira et al which they come into contact. One of the best characterized heterochromatin proteins in higher eukaryotes is HP1 (Heterochromatin Protein 1), which was ®rst identi®ed in a screen for monoclonal antibodies that stained Drosophila polytene chromosomes (James and Elgin, 1986). The HP1 family, which includes three proteins, seems to play a role in assembly of multimolecular complexes in chromatin. HP1 interacts with multiple nuclear proteins such as the lamin B receptor, BRG1/SNF2b (a component of the SWI/SNF complex), ORC1 and ORC2 (two components of the origin recognition complex that binds to origins of replication), the Drosophila dominant suppressor of`Position Eect Variegation' (PEV) Suv(ar)3-9, and the intermediary transcription factors TIF1a and TIF1b (KAP-1/KRIP-1) (Le Douarin et al., 1996; Pak et al., 1997; Tschiersch et al., 1994; Ye and Worman, 1996) .
The lamin B receptor or LBR is a component of the nuclear envelope that binds B-type lamins and doublestranded DNA, and can act as a chromatin anchoring site at the nuclear envelope (Pyrpasopoulou et al., 1996) . HP1 may promote gene silencing through LBRmediated association with the nuclear membrane. A recent study shows an interaction between HP1 and the nuclear envelope (Kourmouli et al., 2000) . Furthermore, in yeast, chromatin associated with the nuclear membrane is transcriptionally silenced (Andrulis et al., 1998) .
TIF1b is thought to be a co-repressor for the KRuÈ ppel-Associated Box (KRAB) domain protein family (Le Douarin et al., 1996) . It has been shown that TIF1b colocalizes with mouse HP1 in heterochromatin (Ryan et al., 1999) , although the physiological signi®cance of this association in still unclear. HP1 stimulates silencing by TIF1b (Nielsen et al., 1999) . Interestingly, an inhibitor of histone deacetylases (trichostatin A) interferes with this silencing (Nielsen et al., 1999) , suggesting a possible functional link with histone deacetylation.
Concerning Suv(ar)3-9, inactivation of its homologue Clr4 by mutation in the yeast Schizosaccharomyces pombe relieves heterochromatin silencing at centromeres (Ivanova et al., 1998) . Since HP1 is known to interact with Suv(ar)3-9 (Aagaard et al., 1999) , it is reasonable to suppose that HP1 might be involved in the silencing function of Suv(ar)3-9.
Gene localization to eu-or hetero-chromatin seems to be an important element in transcriptional control. Heterochromatin, however, has been studied mainly at the level of genes that are inactivated in aǹ irreversible' manner, for example during X chromosome inactivation or cell dierentiation. It is not known whether this type of regulation also applies to genes which are switched on and o repeatedly during the lifespan of a cell, such as cell cycle regulated genes. During interphase, chromosomes can relocate to dierent parts of the nucleus in a cell cycle-dependent manner (Li et al., 1998) . This suggests that genes can be relocated to active or inactive regions of the chromatin in a cell cycle-dependent manner or upon triggering of physiological processes such as dierentiation. It will be of interest to unravel the molecular mechanism that regulates subnuclear localization of speci®c loci, and to study gene localization in dierent situations (proliferation/dierentiation). In Drosophila, gene silencing by heterochromatin might involve the movement of a gene from one area of the nucleus to another (Csink and Heniko, 1996; Dernburg et al., 1996; Heniko et al., 1995) . In mammals, gene silencing by relocation to heterochromatin may also be observed. Indeed, Ikaros, a transcriptional regulator of lymphoid dierentiation, seems to repress transcription by relocating genes from active foci in the nucleoplasm to inactive foci of chromatin near the centromeres (Brown et al., 1997) . Together, these results strongly suggest that heterochromatin may silence genes by a mechanism involving their movement from an active chromosomal region to a nuclear compartment in which transcription is actively suppressed.
Rb and silencing of E2F-regulated genes: an epigenetic process?
As stated above, Rb inhibits E2F transcriptional activity at least partly by recruiting chromatin remodeling factors. Indeed, to inhibit E2F-regulated transcription, Rb recruits class I histone deacetylases (HDAC 1 and 2). Furthermore, histone H4 acetylation varies in a cell cycle-dependent manner on E2F target promoters (R Ferreira et al., 2001, unpublished observations; Takahashi et al., 2000) , and HDAC1 is physically associated with some of these promoters at speci®c stages of the cycle (R Ferreira et al., 2001, unpublished observations) . Rb also recruits BRG1 or SNF2, two members of the ATP-dependent remodeling complex SWI/SNF. Rb can be detected in complexes containing both HDAC1 and BRG1, or only BRG1 (Zhang et al., 2000) . These distinct Rb complexes might act on distinct E2F-regulated genes during the cell cycle, in a gene-dependent context. In addition, Rb complexes might also include a histone methyltransferase, most likely Suv3-9H1, which seems to be involved in repression (Didier Trouche, personal communication) . Rb also recruits the DNA methyltransferase DNMT1 to inhibit E2F-driven transcription , although it is not yet clear whether the catalytic function of DNMT1 is required for this inhibition. DNA methylation of E2F-dependent promoters could thus participate in repressing the activity of these promoters, and indeed methylation of E2F DNA-binding sites prevents the binding of E2F proteins (Campanero et al., 2000) . Although there has as yet been no demonstration of such a mechanism in physiological situations, some E2F-binding sites have been shown to be methylated in human cancers. For example, an E2F-binding site within the CpG-rich promoter of the RB1 gene itself is abnormally methylated in some tumors. This E2F site seems to be required for cell cycle regulated Rb transcription, although, in this case, it is not clear whether the site is involved in promoter repression, activation, or both. Methylation leads to the recruitment of the methylcytosine-binding protein MeCP2. These results suggest that the interaction between MeCP2 and the methylated version of an E2F site represents a step towards Rb promoter inactivation in tumor cells. This aberrant methylation of E2F sites may be a consequence of DNMT1 recruitment by Rb.
The function of the Rb/DNMT1 interaction in normal cells is still a matter of conjecture. For example, it could be involved in the cycle-dependent repression of E2F target promoters in proliferating cells. Perhaps more likely, Rb/DNMT1 complex could also be involved in the silencing of proliferationassociated E2F target genes in dierentiating cells. Indeed, Rb plays a central role in the process of terminal dierentiation in many systems (for reviews see Dyson, 1998; Mulligan and Jacks, 1998) . In muscle, for example, Rb is essential for the proliferation block that is required for dierentiation to occur. In terminally dierentiated muscle cells (myotubes), E2F and other proliferation associated genes become unresponsive to growth inducing signals. The mechanism of this`irreversible' repression is likely to be distinct from that employed in cycling cells, and, for example, might involve methylation of the promoter DNA. Finally, Rb also interacts with the histone methyltransferase Suv39H1, with which it cooperates to inhibit E2F activity (Didier Trouche, personal communication) . The histone methyltransferase could in turn facilitate the recruitment of HP1, which could occur through at least two mechanisms. On the one hand, Suv39H1 interacts directly with HP1 (Aagaard et al., 1999) ; on the other hand, methylation of lysine 9 in histone H3 generates a high anity binding site for HP1 in native chromatin . HP1, in turn, seems to be able to recruit histone deacetylases (Nielsen et al., 1999) and/or remodeling complexes such as SWI-SNF (Le Douarin et al., 1996) to repress transcription. Interestingly, since HP1 is associated with heterochromatin, an involvement of HP1 would suggest that, at some point, E2F target promoters might be localized in heterochromatin ± either during the cell cycle or, more likely, upon triggering of terminal dierentiation and permanent exit from the cell cycle. In our working model (Figure 1) , the irreversible inhibition of E2F-regulated genes in dierentiated cells would occur by DNA methylation and transfer of the genes to the heterochromatin compartment. Such a mechanism has been described Figure 1 A model for E2F target gene regulation. In cycling cells (proliferation), E2F target genes are regulated by the cyclic recruitment of HATs and HDACs but remain in the euchromatin compartment (euchromatin). In dierentiating cells (dierentiation), E2F target genes are methylated both on DNA and on histone H3, which triggers the recruitment of MeCP2 and HP1, the relocation of the genes in heterochromatin, and their silencing through HDACs. Ac: Acetyl group; Me: Methyl group; R: Restriction point. Photograph was kindly provided by Dr Francine Puvion-Dutilleul for genes targeted by the transcriptional regulator Ikaros. In our model, E2F target promoters would remain in euchromatin and retain some level of accessibility throughout the cell cycle. In dierentiating cells, on the other hand, they would be found in heterochromatin, where they would take on a closed, inaccessible structure. The initial state of the dierent E2F-target genes, either open or closed, would be determined by their sub-nuclear localization. In order to understand how cell proliferation is regulated in cycling and dierentiating cells, it is of special importance to test this hypothesis.
